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Abstract We isolated a novel gene designated spinal cord-
derived growth factor (SCDGF). Its expression was increased in
chick spinal cords with embryonic development and decreased
after hatching. The amino acid sequences of chick and human
SCDGFs revealed a putative signal sequence followed by a CUB
domain and a region homologous to the members of the platelet-
derived growth factor/vascular endothelial growth factor family.
Furthermore, human SCDGF secreted from the cells showed a
mitogenic activity for 10T1/2 cells in vitro. These results led us to
speculate that SCDGF plays an important role in the develop-
ment of the spinal cord. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
To understand the function of the nervous system in ma-
turity, it is important to determine the mechanism by which
the nervous system is formed. During neural development,
cells di¡erentiate to speci¢c types of neurons and undergo
migration, synapse formation and cell death precisely with
respect to time and location [1^5]. Accumulating evidence in-
dicates that morphological di¡erentiation is based on cell^cell
interactions through molecules which are located on cell sur-
faces or secreted from cells [2,3]. Therefore, one of the ap-
proaches to reveal the mechanism underlying neural di¡eren-
tiation is to identify molecules, expression of which changes
during development.
The development of the spinal cord has been extensively
studied morphologically using chick embryos [6,7]. One of
the phenomena which occurs during the development is the
so-called naturally occurring neuronal cell death: The large
ventral horn cells, probably motoneurons, reach their maxi-
mum number at embryonic day (E) 5.5 and almost half of
them die until E10 in the chick embryo [8]. The trophic de-
pendency hypothesis is now generally accepted as the mecha-
nism of this motoneuronal cell death [9^11].
The present study was conducted to isolate molecules re-
lated to di¡erentiation of the spinal cord in chick embryos. To
this aim, using the di¡erential display procedure, we isolated
several genes, expressions of which changed drastically from
E4 to E10. Among them, here we report a novel gene desig-
nated spinal cord-derived growth factor (SCDGF), the expres-
sion of which increased within the limited period of embry-
onic development of chick spinal cords. The result indicates
that SCDGF is secreted from the cells and exhibits a mito-
genic activity in vitro. A part of this study was communicated
elsewhere [12].
2. Materials and methods
2.1. Animals and cell lines
Fertilized white Leghorn chicken eggs were purchased from a local
poulterer (Miyake Eggs). The eggs were incubated at 37‡C in a hu-
midi¢ed egg chamber. Chinese hamster CHO-K1 cells and mouse
10T1/2 cells obtained from the RIKEN Cell Bank were propagated
in Dulbecco’s modi¢ed Eagle’s medium and basal medium Eagle
(Gibco BRL), respectively, supplemented with antibiotics (penicillin
(10 U/ml, Meiji) and streptomycin (50 Wg/ml, Meiji)) and 10% heat-
inactivated fetal bovine serum (FBS) (Mitsubishi Kasei).
2.2. RNA isolation, di¡erential display and cDNA cloning
For di¡erential display, 5P-rapid ampli¢cation of cDNA ends
(RACE) and Northern blotting, total RNAs were extracted from
the chick spinal cords and the cultured cells by the LiCl precipitation
method. The di¡erential display method was performed using the
RNAimage kit (GenHunter) with Ampli Taq Gold (Perkin-Elmer)
and [K-35S]dATP (NEN). Samples were resolved in parallel lanes on
6% denaturing polyacrylamide gels. The di¡erentially expressed
cDNAs excised from the gels were reampli¢ed, cloned into the pT7-
Blue(R) vector (Novagen) and sequenced. To obtain a full-length
open reading frame (ORF), 5P-RACE was carried out using the
5P-RACE System, version 2.0 (Gibco BRL). The ¢rst strand cDNA
was synthesized from the total RNA using a speci¢c primer designed
from the sequence of each gene with SUPERSCRIPT II reverse tran-
scriptase (Gibco BRL). Homopolymeric (oligo-dC) tails were added
with dCTP to the 3P-ends of the cDNAs using terminal deoxynucleo-
tidyl transferase (Gibco BRL). PCR reactions were performed for
ampli¢cation of the products using the 5P-GGCCACGCGTCGAC-
TAGTACGGGIIGGGIIGGGIIG-3P primer and a speci¢c primer
for each gene. The 5P-RACE products were subcloned into the pT7-
Blue(R) vector and sequenced on both strands. Sequencing was per-
formed using a dye-terminator cycle-sequencing ready reaction kit
(Perkin-Elmer). Each sample was electrophoresed with an ABI 377
sequencer (Perkin-Elmer).
2.3. Isolation of human SCDGF cDNA
A homology search against the dbEST database of GenBank based
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on the amino acid sequence of cSCDGF was performed using the
TBLASTN program. Two human ESTs (GenBank accession numbers
W21436 and AA759138) showed signi¢cant similarity to cSCDGF.
Based on the sequences of these ESTs, two primers (5P-GAAGTT-
GAGGAACCCAGTGA-3P and 5P-ACGTCGGTGAGTGATTTGT-
G-3P) were used for PCR to isolate a cDNA fragment from a human
fetal brain cDNA library. Using this fragment as a probe, a full-length
hSCDGF cDNA was isolated from this cDNA library.
2.4. Mitogenic activity assay using hSCDGF stably transfected cells
A DNA fragment containing a full-length hSCDGF, the same frag-
ment followed with the Flag octapeptide coding sequence (hSCDGF-
Flag), and the hSCDGF-Flag lacking the ¢rst 10 amino acids of the
signal sequence (hNS-SCDGF-Flag) were inserted into an expression
vector, pcDNA3 (Invitrogen). CHO-K1 cells were stably transfected
with the control pcDNA3 vector, pcDNA3 containing hSCDGF,
hSCDGF-Flag or hNS-SCDGF-Flag using Lipofectamine1 reagent
(Gibco BRL) according to the manufacturer’s protocol. Three days
after the cells were inoculated at 5U105 cells/ml, the supernatant was
collected and ¢ltered to remove cell debris. The mitogenic activity of
the supernatant was assayed using the mouse 10T1/2 cell line which is
one of the mouse embryo ¢broblast cell lines. The 10T1/2 cells were
seeded at 0.5U105 cells/0.5 ml/well in each well of a 24-well plate, and
0.5 ml of the supernatant was added to the wells in triplicate. The
number of cells was counted under a phase contrast microscope at
indicated days in Fig. 3B.
2.5. Northern blot analysis
Total RNAs (20 Wg) were run on a denaturing formaldehyde-agar-
ose gel and transferred to nylon membranes. RNAs blotted onto the
membranes were hybridized with a [32P]-labeled full-length cSCDGF
or hSCDGF fragment encoding a full-length ORF as the probe at
65‡C in a bu¡er containing 0.5 M sodium phosphate (pH 7.2), 7%
SDS and 1 mM EDTA. The membranes were washed twice for 40 min
at 65‡C by immersing in a solution of 0.2USSC and 0.1% SDS. The
membranes were analyzed with a BAS2000 system (Fuji) and exposed
to an X-ray ¢lm.
3. Results
3.1. Molecular cloning of cSCDGF and hSCDGF
To identify proteins involved in spinal cord di¡erentiation,
we screened genes, expressions of which in chick spinal cords
changed from E4 to E10, by the di¡erential display method.
Twenty-four cDNA fragments of 4200 examined were di¡er-
entially expressed (data not shown). Because sequence analy-
ses indicated that most of the fragments did not contain the
5P-regions, we obtained their full-length ORFs using the 5P-
RACE method. The nucleotide sequence analysis of one of
these cDNAs, the expression of which increased from E4 to
E10, revealed that it is a novel gene and has a sequence of
1038 nucleotides encoding a putative protein composed of 345
amino acids (relative molecular mass of 38 938, Fig. 1A). We
named this novel gene as spinal cord-derived growth factor
(SCDGF). To isolate a mammalian homologue, we screened a
human fetal brain cDNA library as described in Section 2,
and obtained a cDNA clone containing a full-length hSCDGF
cDNA encoding a polypeptide (Fig. 1A). The putative amino
acid sequences of cSCDGF and hSCDGF were 84.1% identi-
cal (Fig. 1A). The hydrophobicity pro¢le of cSCDGF showed
that the N-terminal 14 amino acids were highly hydrophobic
(Fig. 2) and could encode a signal peptide [13]. Based on a
homology search carried out with the BLASTX program us-
ing SWISS-PROT, it was revealed that two structural do-
mains already known followed a putative signal sequence:
residues 47^163, a region homologous to the CUB domain
[14], and residues 234^345, a region homologous to a con-
served region in members of the PDGF/VEGF family.
The result of the homology search indicates that the amino
acid residues 47^163 of SCDGFs are highly homologous to
the CUB domain of the Xenopus neuronal recognition mole-
cule, neuropilin (NP) [15]. Fig. 1B illustrates the multiple
alignment of cSCDGF and hSCDGF compared with the
CUB domains contained in human bone morphogenetic pro-
tein 1 (BMP1) [16], Drosophila dorso-ventral patterning gene
product, tolloid (TLD) [17], human complement subcompo-
nents C1r/C1s [18,19], and NP. SCDGFs showed amino acid
identity of about 30% with these CUB domains. Therefore, we
considered that the region encoded a CUB domain. Although
most of the CUB domains have been reported to contain four
cysteines, both cSCDGF and hSCDGF lack the ¢rst two cys-
teines (Fig. 1B).
Only two chicken genes have been reported in the GenBank
database as members belonging to the PDGF/VEGF family;
cPDGF-A (Accession No. AAF01459) and cVEGF-A (Acces-
sion No. P52582). In a conserved region, cSCDGF showed
30.4% and 26.8% amino acid identities with cPDGF-A and
cVEGF-A, respectively (Fig. 1C). For human genes belonging
to the PDGF/VEGF family, hSCDGF showed 32.1% identity
with both hPDGF-A [20] and -B [21], and 29.5%, 25%, 24.1%
and 24.1% with hVEGF-D [22], -B [23], -C [24] and -A [25],
respectively (Fig. 1C). In addition, cSCDGF and hSCDGF
had the eight cysteine residues, which are conserved among
members of the PDGF/VEGF family and have been shown to
be essential for the correct folding and dimerization by intra-
and intermolecular disul¢de bonding [20^25], although addi-
tional four cysteine residues were also found in this region
(Fig. 1C). Furthermore, the amino acid sequence motif
PXCVXXXRCXGCC, a hallmark of the PDGF/VEGF fam-
ily of growth factors, was conserved though not completely.
The fourth Val residue in the motif was replaced with Leu,
and three amino acids, Asn-Cys-Ala, were inserted before the
last two Cys residues in both cSCDGF and hSCDGF.
3.2. The mitogenic activity of hSCDGF in vitro
Members belonging to the PDGF/VEGF family have been
C
Fig. 1. Deduced amino acid alignments of chick and human SCDGFs. A: Comparison of deduced amino acid sequences of cSCDGF and
hSCDGF. A putative secretory signal peptide is underlined. A bold underline indicates a CUB domain, and PDGF/VEGF homologous regions
are boxed. Amino acids identical between cSCDGF and hSCDGF are shaded. B: Comparison of CUB domains of cSCDGF and hSCDGF
(residues 47^163) with the other CUB domains contained in BMP1 [16], TLD [17], C1s/C1r [18,19] and NP [15]. Amino acids identical to
cSCDGF and hSCDGF are shaded. Asterisks indicate the positions of cysteine residues which are characteristic of the CUB domain. Numbers
on the left indicate amino acid positions relative to the initiator methionine residue. C: Comparison of conserved regions homologous to the
PDGF/VEGF family of cSCDGF and hSCDGF with cPDGF-A chain (GenBank Accession No. AAF01459), hPDGF-A chain [20], hPDGF-B
chain [21], cVEGF-A (GenBank Accession No. P52582), hVEGF-A [25], hVEGF-B [24], hVEGF-C [23] and hVEGF-D [22]. Amino acids iden-
tical to those of SCDGFs are shaded. Asterisks indicate the cysteine residues which are characteristic of the PDGF/VEGF family, and pluses
indicate the additional cysteine residues speci¢c to SCDGF. A conserved sequence motif, PXCVXXXRCXGCC, in all members of the PDGF/
VEGF family is denoted under the compared sequences. Numbers on the left indicate amino acid positions relative to the initiator methionine
residue.
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reported to be growth factors with mitogenic activities in vivo
or in vitro [22^28]. Therefore, we examined whether hSCDGF
protein is secreted from cells and acts as a growth factor. We
generated CHO-K1 cells stably transfected with the mamma-
lian expression vector containing hSCDGF, hSCDGF-Flag or
hNS-SCDGF-Flag (see Section 2). The expression of their
mRNAs in the transfectants was veri¢ed by Northern blot
analysis using a probe containing the hSCDGF cDNA (Fig.
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3A). At the expected size, a single band was detected for each
of the transfectants except that for the CHO-K1/vector,
although its intensity in CHO-K1/hSCDGF cells was about
30-fold stronger than that in CHO-K1/hSCDGF-Flag or
CHO-K1/hNS-SCDGF-Flag cells (data not shown). The mi-
togenic activities of the culture supernatants of these trans-
fectants were examined by adding them to 10T1/2 cell cul-
tures, which was been shown to respond to PDGF [29]. The
supernatants of CHO-K1/hSCDGF or CHO-K1/hSCDGF-
Flag cells stimulated the proliferation of 10T1/2 cells (Fig.
3B). However, no mitogenic activity of the supernatant from
the CHO-K1/vector or CHO-K1/hNS-SCDGF-Flag was de-
tected (Fig. 3B). The activity of the supernatant of CHO-
K1/hSCDGF was stronger than that of CHO-K1/hSCDGF-
Flag.
3.3. Developmental pattern of cSCDGF mRNA expression in
chick spinal cords
The developmental changes in cSCDGF mRNA expression
in chick spinal cords were examined by Northern blot hybrid-
ization using the probe containing the cSCDGF ORF. A sin-
gle band of approximately 3.2 kb was detected (Fig. 4). The
level of expression of this mRNA gradually increased from E4
to E10. It was highest at E12^16 and rapidly decreased to a
low level after hatching.
4. Discussion
In this study, we identi¢ed a novel gene, cSCDGF, the ex-
pression of which increased in chick spinal cords during em-
bryonic development and then decreased after hatching. The
putative amino acid sequences of cSCDGF and hSCDGF
revealed a signal sequence consisting of 14 hydrophobic ami-
no acids at its N-terminus, followed by a region homologous
to the CUB domain and a region homologous to the con-
served region of PDGF/VDGF family members.
Fig. 2. Schematic structure and hydrophobicity pro¢le of cSCDGF.
The Cs indicate the relative positions of the cysteine residues which
are characteristic of the PDGF/VEGF family. The shaded box indi-
cates the putative signal peptide. The numbers under the structural
map are amino acid positions relative to the initiator methionine
residue. CUB, CUB domain; PDGF/VEGF, a region homologous
to a conserved region in members of the PDGF/VEGF family.
Analysis of hydrophobicity was performed by the DNASIS ver. 3.0
program (Hitachi Software Engineering) using the parameter of
Kyte and Doolittle [33].
Fig. 3. Mitogenic activity of the supernatants of CHO-K1 cells stably transfected with hSCGDF. A: Northern blot analysis of hSCDGF
mRNA expression in CHO-K1/vector, CHO-K1/hSCDGF, CHO-K1/hSCDGF-Flag and CHO-K1/hNS-SCDGF-Flag cells. The expected position
of hSCDGF mRNA is indicated by an arrow at the right side. B: Proliferation of 10T1/2 cells incubated with the supernatant from CHO-K1/
hSCDGF (circles), CHO-K1/hSCDGF-Flag (triangles), CHO-K1/NS-hSCDGF-Flag (squares) or CHO-K1/vector (solid circles). Results represent
the mean þ S.D. of three independent experiments performed in triplicate.
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The CUB domain was speculated as an extracellular do-
main of approximately 110 residues and a widespread module
found in several proteins. Each of them is functionally di¡er-
ent but developmentally regulated [14]. Therefore, we com-
pared the amino acid sequences of CUB domains of cSCDGF
and hSCDGF with the CUB domains of other proteins, such
as BMP1, TLD, C1r/C1s and NP (Fig. 1B). Notably,
although most of the CUB domains reported have four cys-
teine residues which have been shown to form two disul¢de
bridges [14], both cSCDGF and hSCDGF lacked the ¢rst two
cysteines. This is also the case for the ¢rst domain of C1r/C1s
[18,19], MASP1/2 [30] and the 13th domain of cubilin [31],
although the structural and functional signi¢cance of the lack
of the ¢rst two cysteines in CUB domains remains unknown.
VEGFs are thought to be key factors in vasculogenesis and
angiogenesis due to their speci¢c mitogenic activity on endo-
thelial cells, and PDGF-A and -B are known to be potent
mitogens for smooth muscle cells, glial cells and several other
types of cells [22^26]. It was also shown that VEGF-A and
PDGFs have a conserved region which expresses mitogenic
activity. Based on the structural analysis, cSCDGF and
hSCDGF contained a region homologous to the conserved
region in PDGF/VEGF family members (Fig. 1C). The
most characteristic feature of SCDGF is that it contains a
region homologous to the CUB domain, although none of
the known members of the PDGF/VEGF family has been
reported to possess a CUB domain. These structural charac-
teristics suggest that SCDGF is very similar to members of the
PDGF/VEGF family, however, diverged and unique. There-
fore, we named this gene as spinal cord-derived growth factor
(SCDGF).
Because of the structural similarity of SCDGF with the
members of PDGF/VEGF family, we examined the mitogenic
activity of the SCDGF protein. The supernatants of the
CHO-K1/hSCDGF and CHO-K1/hSCDGF-Flag cells acti-
vated proliferation of 10T1/2 cells (Fig. 3B). However, when
a part of the putative signal sequence was deleted, no mito-
genic activity was detected (Fig. 3B). The results suggest that
SCDGF is secreted from the cells, probably with the aid of
the N-terminal hydrophobic region as a signal peptide, and
acts as a growth factor based on its mitogenic activity on
10T1/2 cells. The mitogenic activity of the supernatants of
CHO-K1/hSCDGF cells was higher than that of CHO-K1/
hSCDGF-Flag cells (Fig. 3B). This is probably due to the
di¡erent expression level of hSCDGF mRNA (Fig. 3A) and/
or the addition of a Flag tag at the C-terminus.
During the developmental period we examined, the
cSCDGF mRNA level gradually increased from E4 to E10
and its expression was highest from E12 to E16, and subse-
quently decreased rapidly after hatching (Fig. 4). Although
the function of SCDGF in vivo is not clear, one of the pos-
sible functions is its mitogenic action on speci¢c types of
spinal cord cells during embryonic development. However, it
is known that many kinds of growth factors do not only
exhibit mitogenic activities but also perform other functions
[26,32]. Therefore, further analysis is necessary to investigate
the function of SCDGF during development.
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